Latest Funding News

AGL Energy reported a 42% drop in statutory profit for the half-year ended December 2025, despite a modest revenue decline and growth in customer services. The company declared a higher interim dividend, underscoring confidence amid operational challenges and a strategic pivot to renewables.

Commonwealth Bank of Australia’s latest Basel III Pillar 3 disclosures reveal steady capital adequacy ratios and proactive adaptation to evolving regulatory standards as of December 2025.

HomeCo Daily Needs REIT delivered consistent earnings growth in 1H FY26, underpinned by strong operational execution and disciplined capital management. The REIT reaffirmed its FY26 guidance while progressing a substantial development pipeline valued at over $650 million.

Commonwealth Bank of Australia reported a robust half-year result for December 2025, with a 6% rise in cash NPAT to $5.445 billion and a 10-cent dividend increase, underpinned by disciplined growth and strong capital management.

Commonwealth Bank of Australia reported a 5% rise in net profit for the half-year ended December 2025, balancing lending growth with margin pressures and increased technology investment.

HomeCo Daily Needs REIT has reported steady growth in funds from operations for the first half of FY26, supported by strong asset valuations and operational metrics, while reaffirming its full-year guidance.

Commonwealth Bank of Australia reported a 5% increase in statutory net profit after tax to $5.367 billion for the half year ended December 2025, supported by lending growth and improved credit quality despite margin pressures and higher expenses. The bank declared a fully franked interim dividend of $2.35 per share.

HomeCo Daily Needs REIT has reported a robust half-year result, doubling its profit to $243.5 million driven by significant fair value gains on its property portfolio, while maintaining stable distributions to unitholders.

Elanor Investors Group has secured securityholder approval for a $125 million recapitalisation with Rockworth Capital Partners and the acquisition of Firmus Capital, marking a pivotal step in stabilising its balance sheet and positioning for growth.

Alice Queen Limited has successfully raised an additional $280,000 from unrelated investors, increasing the size of its tranche two placement to fund key exploration projects and working capital.

Island Pharmaceuticals has confirmed the material significance of recent FDA feedback on its Galidesivir development pathway and addressed ASX queries on disclosure timing and capital raising activities.

Tartana Minerals secures $4.5 million to ramp up exploration at its Nightflower Silver-Lead-Zinc-Antimony project and appoints a new director to bolster governance.